These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39536847)
1. Efficacy of dual antiplatelet therapy after ischemic stroke according to hsCRP levels and CYP2C19 genotype. Yang M; Xu J; Xue J; Pan Y; Cheng A; Gao F; Meng X; Miao Z; Wang Y; Wang Y; Am Heart J; 2025 Feb; 280():89-97. PubMed ID: 39536847 [TBL] [Abstract][Full Text] [Related]
2. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Maas DPMSM; Willems LH; Kranendonk J; Kramers C; Warlé MC Drugs; 2024 Oct; 84(10):1275-1297. PubMed ID: 39235670 [TBL] [Abstract][Full Text] [Related]
3. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial. Fanaroff AC; Wojdyla DM; Granger CB; Goodman SG; Aronson RS; Windecker S; Mehran R; Alexander JH; Lopes RD Circ Cardiovasc Interv; 2024 Nov; 17(11):e013596. PubMed ID: 39502066 [TBL] [Abstract][Full Text] [Related]
6. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation. Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138 [TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation. Panattoni L; Brown PM; Te Ao B; Webster M; Gladding P Pharmacoeconomics; 2012 Nov; 30(11):1067-84. PubMed ID: 22974536 [TBL] [Abstract][Full Text] [Related]
8. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease. Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994 [TBL] [Abstract][Full Text] [Related]
9. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Mathew RO; Sidhu MS; Rihal CS; Lennon R; El-Hajjar M; Yager N; Lyubarova R; Abdul-Nour K; Weitz S; O'Cochlain DF; Murthy V; Levisay J; Marzo K; Graham J; Dzavik V; So D; Goodman S; Rosenberg YD; Pereira N; Farkouh ME Cardiovasc Drugs Ther; 2024 Jun; 38(3):447-457. PubMed ID: 36445624 [TBL] [Abstract][Full Text] [Related]
11. Impact of short-term aircraft noise on cardiovascular disease risk in the area surrounding London Heathrow airport: the RISTANCO epidemiological study. Gong X; Itzkowitz N; Jephcote C; Adams K; Atilola GO; Gulliver J; Blangiardo M; Hansell A Public Health Res (Southampt); 2024 Dec; 12(13):1-58. PubMed ID: 39648696 [TBL] [Abstract][Full Text] [Related]
12. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
13. Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation. Kim JH; Hong SJ; Cha JJ; Lim S; Joo HJ; Park JH; Yu CW; Ahn TH; Jeong YH; Kim BK; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Shin ES; Lim DS BMC Med; 2024 Aug; 22(1):335. PubMed ID: 39148087 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound and shockwave therapy for acute fractures in adults. Searle HKC; Lewis SR; Coyle C; Welch M; Griffin XL Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008579. PubMed ID: 36866917 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant Data. McCabe JJ; Walsh C; Gorey S; Arnold M; DeMarchis GM; Harris K; Hervella P; Iglesias-Rey R; Jern C; Katan M; Li L; Miyamoto N; Montaner J; Purroy F; Rothwell PM; Stanne TM; Sudlow C; Ueno Y; Vicente-Pascual M; Whiteley W; Woodward M; Kelly PJ Stroke; 2024 Dec; 55(12):2825-2834. PubMed ID: 39479747 [TBL] [Abstract][Full Text] [Related]
17. Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis. Foschi M; De Matteis E; De Santis F; Romoli M; Tassinari T; Saia V; Cenciarelli S; Bedetti C; Padiglioni C; Censori B; Puglisi V; Vinciguerra L; Guarino M; Barone V; Zedde M; Grisendi I; Diomedi M; Bagnato MR; Petruzzellis M; Mezzapesa DM; Di Viesti P; Inchingolo V; Cappellari M; Zivelonghi C; Candelaresi P; Andreone V; Rinaldi G; Bavaro A; Cavallini A; Moraru S; Querzani P; Terruso V; Mannino M; Pezzini A; Frisullo G; Muscia F; Paciaroni M; Mosconi MG; Zini A; Leone R; Palmieri C; Cupini LM; Marcon M; Tassi R; Sanzaro E; Paci C; Viticchi G; Orsucci D; Falcou A; Diamanti S; Tarletti R; Nencini P; Rota E; Sepe FN; Ferrandi D; Caputi L; Volpi G; La Spada S; Beccia M; Rinaldi C; Mastrangelo V; Di Blasio F; Invernizzi P; Pelliccioni G; De Angelis MV; Bonanni L; Ruzza G; Caggia EA; Russo M; Tonon A; Acciarri MC; Anticoli S; Roberti C; Manobianca G; Scaglione G; Pistoia F; Fortini A; De Boni A; Sanna A; Chiti A; Barbarini L; Caggiula M; Masato M; Del Sette M; Passarelli F; Bongioanni MR; Toni D; Ricci S; Sacco S; Ornello R J Neurol Sci; 2024 Nov; 466():123211. PubMed ID: 39244893 [TBL] [Abstract][Full Text] [Related]
18. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
19. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China (E-start): a prospective, multicentre, open-label, blinded-endpoint, randomised trial. Liu Q; Mo S; Wu J; Tong X; Wang K; Chen X; Chen S; Guo S; Li X; Li M; Peng L; Sun X; Wang Y; Sun J; Pu J; Zheng K; Zhang J; Liu Y; Yang Y; Wen Z; Nie X; Feng Y; Lan C; Tang H; Wang N; Li J; Miao Z; Lu X; Ning B; Zhao B; Kang D; Chen X; Zhang Y; Zhang Y; Wang A; Zhu C; Araki Y; Uda K; Yoshimura S; Uchida K; Morimoto T; Yoshioka H; Hasan D; Du R; Levitt MR; Cao Y; Wang S; Zhao J; Lancet Neurol; 2024 Dec; 23(12):1195-1204. PubMed ID: 39577920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]